AR055411A1 - METHOD FOR DIAGNOSING HYPERTENSION. - Google Patents

METHOD FOR DIAGNOSING HYPERTENSION.

Info

Publication number
AR055411A1
AR055411A1 ARP060103854A AR055411A1 AR 055411 A1 AR055411 A1 AR 055411A1 AR P060103854 A ARP060103854 A AR P060103854A AR 055411 A1 AR055411 A1 AR 055411A1
Authority
AR
Argentina
Prior art keywords
hypertension
predisposition
diagnosing hypertension
hsgk
alleles
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Florian Lang
Andreas Busjahn
Friedrich C Luft
Original Assignee
Florian Lang Prof Dr Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florian Lang Prof Dr Med filed Critical Florian Lang Prof Dr Med
Publication of AR055411A1 publication Critical patent/AR055411A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Método para diagnosticar hipertension o una predisposicion a la hipertension que comprende determinar ambos alelos del gen hsgk 1 en una muestra de material biologico de un probando del que se sospecha que padece hipertension o posee una predisposicion a la hipertension. También un medio de diagnostico que comprende medios para determinar ambos alelos del en hsgk 1, al uso de estos medios para preparar un medio de diagnostico para diagnosticar hipertension o una predisposicion a la hipertension y a un conjunto que comprende estos medios.Method to diagnose hypertension or a predisposition to hypertension which comprises determining both alleles of the hsgk 1 gene in a sample of biological material from a test that is suspected of suffering from hypertension or has a predisposition to hypertension. Also a diagnostic means comprising means to determine both alleles in hsgk 1, to the use of these means to prepare a diagnostic means to diagnose hypertension or a predisposition to hypertension and a set comprising these means.

ARP060103854 2005-09-02 2006-09-04 METHOD FOR DIAGNOSING HYPERTENSION. AR055411A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05019149 2005-09-02

Publications (1)

Publication Number Publication Date
AR055411A1 true AR055411A1 (en) 2007-08-22

Family

ID=35520572

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103854 AR055411A1 (en) 2005-09-02 2006-09-04 METHOD FOR DIAGNOSING HYPERTENSION.

Country Status (2)

Country Link
AR (1) AR055411A1 (en)
WO (1) WO2007025792A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2723758C1 (en) * 2019-09-16 2020-06-17 Государственное бюджетное учреждение здравоохранения города Москвы "Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского Департамента здравоохранения города Москвы" (ГБУЗ "НИИ СП ИМ. Н.В. СКЛИФОСОВСКОГО ДЗМ") Method for early prediction of intracranial hypertension in patients with craniocerebral injury
RU2761751C1 (en) * 2021-04-15 2021-12-13 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ГБ им. Гельмгольца" Минздрава России) Method for ultrasound diagnostics of intracranial hypertension

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10113876A1 (en) * 2001-03-21 2002-09-26 Eberhard Karls Uni Medizinisch Quantitative diagnosis of genetically related hypertension, by correlating blood pressure with overexpression or modification of human sgk family proteins
DE10305213A1 (en) * 2003-02-07 2004-08-26 Florian Prof. Dr.med. Lang Use of a new polymorphism in the hsgk1 gene to diagnose hypertension and use of the sgk gene family to diagnose and treat Long-Q / T syndrome

Also Published As

Publication number Publication date
WO2007025792A1 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
EP2520935A3 (en) Organ-specific proteins and methods of their use
EP2302079A3 (en) Systemic lupus erythematosus diagnostic assay
NZ592358A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2)
WO2007114986A3 (en) Cooperative probes and methods of using them
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008140639A3 (en) Biomarkers and assays for alzheimer's disease
EP4235181A3 (en) Biomarker detection process and assay of neurological condition
BRPI0707645B8 (en) in vitro methods for detecting cancer in an individual and for evaluating the prognosis of an individual having, or suspected of having, ovarian cancer
WO2008098142A3 (en) Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
EP2804001A3 (en) Methods for diagnosing prostate carcinomas
WO2004089187A3 (en) Caries risk test for predicting and assessing the risk of disease
DE602006021777D1 (en) DIAGNOSTIC PROCEDURE FOR PRE-CLAMPING
WO2007056523A3 (en) Methods for diagnosing and monitoring the progression of cancer
DE60228557D1 (en) CANDIDA-PROOF
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
TR201900481T4 (en) Apparatus and kit for immunoassay.
DE602005022709D1 (en) QUANTIFICATION METHOD FOR THE VEGF ISOFORMS OF A BIOLOGICAL SAMPLE
WO2009099905A3 (en) Molecular signatures and biomarkers associated with melanoma and methods of use thereof
MX2009010751A (en) Compositions and methods of detection.
WO2010099137A3 (en) In situ methods for monitoring the emt status of tumor cells in vivo
ATE370414T1 (en) USE OF NICOTINAMIDE N-METHYLTRANSFERASE FOR DIAGNOSING COLORECTAL CANCER
ATE504833T1 (en) METHOD FOR DETERMINING THE PHENOTYPE OF CELLS
WO2007061940A3 (en) Method for detecting an inflammatory disease or cancer
WO2009014987A3 (en) Identification and quantification of biomarkers for evaluating the risk of preterm birth
PE20120592A1 (en) METHOD WITH BIOMARKERS FOR THE MONITORING OF A TREATMENT

Legal Events

Date Code Title Description
FA Abandonment or withdrawal